[Skip to Content]
[Skip to Content Landing]
Article
April 1996

Medical Treatment for Cysticercosis

Author Affiliations

Department of Neurology King George's Medical College Lucknow 226003, India

Arch Neurol. 1996;53(4):295. doi:10.1001/archneur.1996.00550040021005
Abstract

We read with interest the points raised against and in favor of medical treatment for cysticercosis.1,2 As in Latin American countries, neurocysticercosis is a common neurological problem in India. Parenchymal neurocysticercosis is the most common cause of symptomatic epilepsy in our country. Subarachnoidal and ventricular and other forms of neurocysticercosis are relatively rare. Praziquantel is less commonly used by us because of the high cost and the potentially serious side effects.

After reaching the brain, cysticercus larva lodges itself in the parenchyma and subsequently passes through many stages.1 Initially when viable larva develop into a small cyst, the patient is usually asymptomatic. Symptom (eg, seizures) develops only when the cyst is attacked by the host immune defense mechanisms. At this stage computed tomographic (CT) scan shows enhancing ring or nodular lesions with variable amounts of perifocal edema.3 In Indian patients with epilepsy, in whom single lesions are

First Page Preview View Large
First page PDF preview
First page PDF preview
×